DYNAMIC-Rectal: Using blood tests to make chemotherapy decisions
The DYNAMIC-Rectal trial is currently in development. This trial will analyse the presence of circulating tumour DNA (ctDNA)... Read More
Running for a cure: Dr Roland Main
This Saturday 14th of April, Roland Main will run 21km as part of the Canberra Times Australian Running... Read More
MODULATE: A new approach to immunotherapy for colorectal cancer patients
Colorectal cancer, or bowel cancer, is the most commonly diagnosed cancer in Australia. If it is diagnosed early,... Read More
Teletrial delivers treatment to rural patients
An innovative model is currently being implemented at Orange Health Service to expand access to the ASCOLT clinical... Read More
Better treatment for elderly patients with MONARCC Trial
Elderly patients with advanced colorectal cancer may soon have milder effective treatment options available to them, as a... Read More
LIBERATE trial could be key to fast and accurate screening
The LIBERATE trial is investigating the accuracy of liquid biopsies as a method of screening for mutation tumour... Read More
Memories of the Aconcagua Gutsy Challenge
Last year, the GI Cancer Institute’s Gutsy Challenge was the most ambitious ever, with eight trekkers climbing Mt... Read More
DYNAMIC-III trial could provide more effective screening
The potential of liquid biopsies in cancer screening will be tested in the DYNAMIC-III trial, which is... Read More
Colorectal Cancer Awareness Month: How our research contributes
Colorectal cancer is a cancer that starts in the colon or the rectum, when cells in the body... Read More
Lynch Syndrome – a personal story from our CAP member Autumn Tansey
My gratitude for the opportunity to have lived the last 7 years with Lynch Syndrome is never far... Read More
Surviving Oesophageal Cancer – Bob Geaghan’s Story
To support our work on clinical trials for Oesophageal and other GI Cancers please Read More
Raising Awareness on World Cholangiocarcinoma Day – Feb 14
Bile duct trials offer hope Support from donors has funded AGITG’s role in key international initiatives to find better... Read More
Employment Opportunities
The GI Cancer Institute is embarking on a program of significant growth over the next five years resulting... Read More
World Cancer Day Feb 4 #WeCanICan
The GI Cancer Institute supports World Cancer Day – Feb 4 2018. World Cancer Day 2018 is focused on how... Read More
Can exercise prior to oesophageal cancer surgery improve outcomes?
Expert speakers outlined the benefits of exercise before surgery for oesophageal cancer during a recent lecture at the... Read More
Making the cut – Miles Gray honours his friend to highlight need for GI Cancer research
Since switching his hometown in sunny Queensland to Tasmania’s rugged surroundings, Miles Gray – a full-time physiotherapist and... Read More
Report in to Funding for Low Survival Cancers Submitted to Parliament
The GI Cancer Institute welcomes the report from the Senate Select Committee investigating research funding for cancers with... Read More
DOCTOR Genomics Study lays important ground work for future Oesophageal cancer research
The DOCTOR trial is a highly successful clinical trial, run through the GI Cancer Institute’s national member network, that... Read More
Thank you for your support – GI Cancer Institute recognises #GivingTuesday
Tuesday 28th November is #GivingTuesday – global... Read More
Recognising Pancreas Cancer Awareness Month: 1-30th November
As a member of the Pancreatic Cancer Alliance, in Australia, the GI Cancer Institute was involved this year in shining a light on pancreatic cancer and Demanding Better. For Patients. For Survival. to mark World Pancreatic Cancer Day. This short video shows highlights from our joint event with the following Pancreatic Cancer... Read More